Pebblebrook (PEB) Q2 2026 earnings review
Strong Q2 Execution Clouded by a Cautious Q3 Outlook
Pebblebrook delivered a textbook beat-and-raise in Q2, leveraging a massive recovery in San Francisco and robust pricing power at its resorts. Same-Property Hotel EBITDA jumped 7.1% to $123.3M, crushing the high end of guidance. Management effectively squeezed operating leverage out of a 4.8% revenue increase by holding expense growth to just 3.8%. However, while the full-year outlook was raised, the implied back-half of the year is notably soft. Q3 RevPAR guidance points to a sharp deceleration to 1-3% growth, with management explicitly citing short booking windows and macroeconomic uncertainty as reasons to temper enthusiasm.
🐂 Bull Case
The long-awaited San Francisco turnaround is fully materializing. Q2 RevPAR surged 16.0% and Hotel EBITDA jumped 24.6%, driven by robust citywide convention activity and recovering business transient demand.
Pebblebrook continues to successfully defend margins. Same-Property Total Expenses grew only 3.8%, allowing EBITDA margins to expand by 67 basis points. A recent 27% drop in property insurance premiums will provide a $6.1M annual tailwind.
🐻 Bear Case
The post-Q1 demand surge is fading. Q3 Same-Property RevPAR guidance of 1.0% to 3.0% marks a significant deceleration from Q2's 6.5% and Q1's 11.8% growth.
While SF and resorts thrive, Washington D.C. (-9.9% RevPAR) and San Diego (-9.1% RevPAR) are hemorrhaging revenue due to weak government travel and poor convention calendars.
⚖️ Verdict: ⚪
Neutral. The Q2 operational execution was flawless, and the margin protection is commendable. However, the steep deceleration in Q3 guidance and the severe underperformance in DC and San Diego prevent a fully bullish stance.
Key Themes
San Francisco's Accelerating Recovery
San Francisco flipped from a historical laggard to the portfolio's premier growth engine. The market delivered 16.0% RevPAR growth and 24.6% Hotel EBITDA growth. The rebound spans multiple segments: corporate/tech conventions, improving business transient demand tied to office leasing, and returning leisure tourism. This validates management's thesis of a multi-year recovery runway constrained by historically low new supply.
Resorts Flex Pricing Power & Out-of-Room Spend
The resort portfolio remains a powerhouse. Total RevPAR climbed 10.9%, outpacing room revenue and signaling heavy guest spending on food, beverage, and amenities (resort F&B grew nearly 11%). More importantly, resorts achieved a 7.5% increase in average prices (ADR), which flowed directly to the bottom line, driving an 18.5% surge in Hotel EBITDA.
Operational Efficiency & Insurance Cost Tailwinds
Pebblebrook generated 67 basis points of EBITDA margin expansion through strict cost discipline. On a per-occupied-room basis, total expenses were held to a 2.0% increase. Additionally, management secured a highly favorable property insurance renewal on June 1, cutting premiums by 27% (a $6.1M annual savings). This was driven by better insurance market conditions and recent asset-hardening investments.
Washington D.C. and San Diego Collapse
Geographic concentration risk materialized aggressively in two key markets. Washington D.C. RevPAR plummeted 9.9% due to persistent weakness in government-related demand. Concurrently, San Diego's urban hotels saw RevPAR decline 9.1% entirely due to a weaker convention calendar. Excluding these four San Diego properties, the overall portfolio's Same-Property RevPAR would have been 8.6% instead of 6.5%.
Creative Capital Allocation & Deleveraging
Management executed a highly accretive disposition in Q2. They sold the Chamberlain West Hollywood for $43.5M. Instead of just taking cash, they accepted $33.7M of Pebblebrook's own preferred shares at an agreed value of $26.1M, retiring them at a massive 23% discount. This simultaneous asset-shedding and liability-management maneuver successfully lowered the net debt-to-TTM EBITDA ratio to 5.3x.
Shortened Booking Windows and Macro Paranoia
Despite a raised full-year outlook, management’s tone regarding the second half of the year remains highly defensive. The Q3 and H2 outlook assumes deceleration, driven by short booking windows and 'geopolitical, policy, and broader economic uncertainty.' If the consumer weakens further, the lack of long-term visibility leaves the back half of the year vulnerable to sudden demand shocks.
Other KPIs
Deleveraging is steadily progressing. The ratio dropped to 5.3x as of June 30, driven by EBITDA growth, disciplined debt reduction, and strategic asset sales. The company has no major debt maturities until 2028, with the upcoming December 2026 convertible notes already fully funded.
Up 4.8% YoY. This outpaced the high end of the company's own outlook. The mix shift is notable: transient revenue grew nearly 10% on strong ADR growth, while group revenue declined slightly due to convention calendar holes in Boston and San Diego.
Up 4.6% YoY and $0.06 over the high end of the company's outlook. The tight conversion of EBITDA growth to FFO per share underscores the value of the recent preferred share repurchases and interest expense management.
Guidance
Decelerating aggressively from Q2's +6.5%. This signals that the easy comparables and event-driven boosts of Q1 and Q2 are fading, requiring the company to rely on pure organic pricing and occupancy gains in a softer macro environment.
Decelerating sequentially from the $116.2M delivered in Q2. Represents a cautious stance as the company faces tough convention comps in select markets and normalized leisure travel.
Accelerating/Raised. The midpoint was raised by $8.5M from the prior outlook, entirely reflecting the Q2 outperformance. Management explicitly noted they are 'maintaining our prior assumptions for the second half of the year,' refusing to extrapolate Q2's strength into Q3/Q4.
Stable. This normalized capital run-rate continues to be a tailwind for discretionary free cash flow, allowing the company to aggressively pursue debt reduction and share repurchases without sacrificing asset quality.
Key Questions
San Diego Convention Rebound Timing
San Diego suffered a 9.1% RevPAR decline due to a weak convention calendar. Is this simply a timing issue with groups shifting to Q3/Q4, or does this represent a structural loss of business to competing markets?
Washington D.C. Government Travel Floor
With D.C. RevPAR down nearly 10%, have we found the bottom for government-related demand? What leading indicators are you tracking to suggest a return to normalization in this segment?
Preferred vs Common Share Repurchase Strategy
You successfully retired preferred shares at a 23% discount during the Chamberlain sale. Looking at H2, how does the board weigh the relative attractiveness of retiring deeply discounted preferreds versus buying back common stock at current valuations?
Q3 Deceleration Drivers
Your Q3 RevPAR guidance of 1-3% implies a steep drop from Q2's 6.5%. Aside from general macro caution, are you seeing real-time softening in forward bookings, or is this primarily a function of tougher year-over-year comparables?